Life after treatment for follicular lymphoma brings long-term physical and emotional challenges, including immune system ...

The stent hadn’t helped after all; the impacted kidney had, in fact, been irreversibly damaged and was now functioning at a ...

A rare case has been reported of diffuse large B-cell lymphoma (DLBCL) presenting initially as cold agglutinin disease (CAD). The report, published in the Kaohsiung Journal of Medical Sciences, ...

Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...

DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...

Wojciech Jurczak, MD, PhD, ​​discusses the future of B-cell lymphoma therapy, with a focus on Bruton's tyrosine kinase ...

• In advanced-stage HL, reduction of chemotherapy or radiotherapy after a negative interim PET scan is probably beneficial for overall survival. • Treatment escalation with rituximab after a positive ...

A young woman who thought her anxiety was due to the recent death of her father was correctly diagnosed with blood cancer by ...

A man misdiagnosed with Non-Hodgkin lymphoma, who took cannabis instead of the expensive treatment, leading to a drug debt ...

It usually responds well to treatment and is often cured. About one in five people with lymphoma have follicular lymphoma. This is a slow-growing form that mainly affects older adults. It might ...

TAZVERIK ® is a registered trademark of Epizyme Inc., an Ipsen company.